Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
That's ok, but if inhibiting expression of ACE2 was an issue for inpatient use of ABET, then it's use of in current p3 trail would have shown safty issues for sure. But it does not.
